T. Rowe Price Associates
PATH icon

T. Rowe Price Associates’s UiPath PATH Stock Holding History

T. Rowe Price Associates’s Portfolio PATH Stock Details PATH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.31M Sell
387,915
-758,579
-66% -$9.66M ﹤0.01% 1476
2025
Q4 		$18.8M Buy
1,146,494
+809,315
+240% +$12.6M ﹤0.01% 1070
2025
Q3 		$4.51M Buy
337,179
+11,178
+3% +$132K ﹤0.01% 1425
2025
Q2 		$4.17M Buy
326,001
+15,456
+5% +$185K ﹤0.01% 1330
2025
Q1 		$3.2M Buy
310,545
+18,619
+6% +$240K ﹤0.01% 1403
2024
Q4 		$3.71M Sell
291,926
-415,194
-59% -$5.49M ﹤0.01% 1371
2024
Q3 		$9.05M Sell
707,120
-461,158
-39% -$5.65M ﹤0.01% 1157
2024
Q2 		$14.8M Sell
1,168,278
-1,194,247
-51% -$20.6M ﹤0.01% 1030
2024
Q1 		$53.6M Sell
2,362,525
-4,541,389
-66% -$106M 0.01% 712
2023
Q4 		$171M Buy
6,903,914
+3,076,247
+80% +$60M 0.02% 439
2023
Q3 		$65.5M Sell
3,827,667
-625,039
-14% -$10.4M 0.01% 600
2023
Q2 		$73.8M Buy
4,452,706
+977,918
+28% +$15.7M 0.01% 596
2023
Q1 		$61M Sell
3,474,788
-229,062
-6% -$3.46M 0.01% 628
2022
Q4 		$47.1M Buy
3,703,850
+705,028
+24% +$8.71M 0.01% 676
2022
Q3 		$37.8M Sell
2,998,822
-2,574,802
-46% -$45.2M 0.01% 731
2022
Q2 		$101M Sell
5,573,624
-16,911,093
-75% -$316M 0.01% 655
2022
Q1 		$485M Sell
22,484,717
-13,106,772
-37% -$442M 0.05% 335
2021
Q4 		$1.54B Buy
35,591,489
+1,684,529
+5% +$83.1M 0.14% 148
2021
Q3 		$1.78B Buy
33,906,960
+10,529,870
+45% +$637M 0.17% 125
2021
Q2 		$1.52B Buy
+23,377,090
New +$1.71B 0.14% 155

Other funds holding PATH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
TAM
TFG Asset Management Grand Cayman, Cayman Islands $515M AUM 24.47% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

T. Rowe Price Associates's PATH Position: Q1 2026 in Review

T. Rowe Price Associates reduced its UiPath (PATH) stake by 66% in Q1 2026, selling an estimated $9.66M and leaving 387,915 shares worth $4.31M. The position accounts for ﹤0.01% of the portfolio, ranked #1476.

T. Rowe Price Associates first reported a position in PATH in Q2 2021 and has held it in 20 quarters since. The position peaked at $1.78B in Q3 2021. 533 funds tracked by Wall St. Rank hold PATH as of Q1 2026.

  • T. Rowe Price Associates held 387,915 shares of UiPath worth $4.31M as of Q1 2026.
  • T. Rowe Price Associates sold 758,579 UiPath shares in Q1 2026, an estimated $9.66M.
  • UiPath made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #1476 holding.
  • T. Rowe Price Associates first reported a position in UiPath in Q2 2021 and has held it in 20 quarters since.
  • T. Rowe Price Associates's UiPath position peaked at $1.78B in Q3 2021.
  • 533 funds tracked by Wall St. Rank held UiPath as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.